OUR SERVICES
Corporate Strategy
Strategic advice for Biotech and MedTech companies on matters related to overall corporate strategy including:
-
Company Formation (Incorporation)
-
Business Fundamentals (Strategic Goals, Value-Inflection Milestones)
-
Structure Building (Workforce Plan, Identification and Engagement of FTEs, or 3rd party consultants/contractors, fractional leadership.
-
Patent/IP Strategy and execution.
-
Commercial Strategy (see below)
-
Financial Estimates. (Market Sizing, OPEX estimates, and P&L projections)
-
R&D, Manufacturing, CMC, Regulatory, Pricing and Market Access considerations.
Investor-Readiness
Assistance for Founders/CEOs of Early-stage companies to prepare for Pre-Seed/Seed Rounds, Angel/Early VC pitches:
-
Financing considerations/Use of Funds (based on Financial Estimates)
-
Exit scenarios/Strategic Deals: define the potential structure of a strategic deals like Paid Pilots, co-development deals and/or Licensing deals (upfront vs milestones and royalties).
-
PITCH DECK creation or "polishing".
-
Executive Summary/One-Pager.
-
Investment Memo.
-
Data Room stocked with Due Diligence materials.
-
PRACTICE: conduct Pitch Practice sessions with Q&A simulating pitches to different kinds of investors (Angels vs. a Life Sciences investor) and potential Strategic Partner (BioPharma Company).
Commercial Planning and Geographical Footprint
Customized effective decision-making tools to help Biotech companies build a solid geographical footprint and develop the best strategy for the successful global launch:
-
Country prioritization and Launch Cadence
-
US "soft-landing" for Ex-US startups.
-
Business Opportunity Sizing (Patient-based country-specific revenue models)
-
Comprehensive Product Launch Plans, (deep expertise in rare disease/orphan drugs, Cell and Gene Therapy and other Specialty Therapeutics).
-
Go-To-Market Model design and assistance for successful execution.
-
Identification, selection and engagement of local team members or regional partners.